Nuclear magnetic resonance and molecular modeling analysis of the interaction of the antimalarial drugs artelinic acid and artesunic acid with β-cyclodextrin

Journal of Pharmaceutical Sciences

Volumn 93, Issue 8, 2004, Pages 2076-2089

  Hartell, Mark G ^a   Hicks, Rickey ^a   Bhattacharjee, Apurba K ^a   Koser, Brandon W ^a   Carvalho, Keith ^a   Van Hamont, John E ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Artelinic acid; Molecular modeling; NMR; cyclodextrin

Indexed keywords

ANTIMALARIAL AGENT; ARTELINIC ACID; ARTESUNATE; BETA CYCLODEXTRIN; CHLOROQUINE; MEFLOQUINE; PYRIMETHAMINE; QUININE; SULFADOXINE;

ANTIBIOTIC SENSITIVITY; ANTIMALARIAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; DRUG POTENCY; DRUG SOLUBILITY; ELECTRICITY; MOLECULAR MODEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PLASMODIUM FALCIPARUM; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 3843141790     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20106     Document Type: Article

References (41)

1. Lin AJ, Klayman DL, Milhous WK. 1987. Anti-malarial activity of new water-soluble dihydroartemisinin derivatives. J Med Chem 30:2147-2150.
2. Posner GH, Paik IH, Sur S, McRiner AJ, Borstnik K, Xie S, Shapiro TA. 2003. Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy. J Med Chem 46:1060-1065.
3. Li QG, Peggins JO, Fleckenstein LL, Masonic K, Heiffer MH, Brewer TG. 1998. The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats. J Pharm Pharmacol 50:173-182.
4. Lin AJ, Miller RE. 1995. Antimalarial activity of new dihydroartemisinin derivatives. 6. alpha-Alkylbenzylic ethers. J Med Chem 38:764-770.
5. van Vianen PH, Klayman DL, Lin AJ, Lugt CB, van Engen AL, van der Kaay HJ, Mons B. 1990. Plasmodium berghei: The antimalarial action of artemisinin and sodium artelinate in vivo and in vitro, studied by flow cytometry. Exp Parasitol 70:115-123.
6. Li QG, Peggins JO, Lin AJ, Masonic KJ, Trotman KM, Brewer TG. 1998. Pharmacology and toxicology of artelinic acid: Preclinical investigations on pharmacokinetics, metabolism, protein and red blood cell binding, and acute and anorectic toxicities. Trans R Soc Trop Med Hyg 92:332-340.
7. Lin AJ, Lee M, Klayman DL. 1989. Antimalarial activity of new water-soluble dihydroartemisinin derivatives. 2. Stereospecificity of the ether side chain. J Med Chem 32:1249-1252.
8. Grigorov M, Weber J, Tronchet MJ, Jefford CW, Milhous WK, Marcic O. 1995. A qsar study of the antimalarial activity of some synthetic 1,2,4-trioxanes. J Chem Inf Comput Sci 35:285-304.
9. Brewster ME, Loftsson T. 2002. The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems. Pharmazie 57:94-101.
10. Stella VJ, Rao VM, Zannou EA, Zia W. 1999. Mechanisms of drug release from cyclodextrin complexes. Adv Drug Delivery Rev 36:3-16.
11. Thompson DO. 1997. Cyclodextrins-Enabling excipients: Their present and future use in pharmaceuticals. Crit Rev Ther Drug Carrier Syst 14: 1-104.
12. Fernandes CM, Ramos P, Falcao AC, Veiga FJ. 2003. Hydrophilic and hydrophobic cyclodextrins in a new sustained release oral formulation of nicardipine: In vitro evaluation and bioavailability studies in rabbits. J Control Release 88:127-134.
13. Rao VM, Haslam JL, Stella VJ. 2001. Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-beta-cyclodextrin as a solubilizing agent. J Pharm Sci 90:807-816.
14. Rode T, Frauen M, Muller BW, Dusing HJ, Schonrock U, Mundt C, Wenck H. 2003. Complex formation of sericoside with hydrophilic cyclodextrins: Improvement of solubility and skin penetration in topical emulsion based formulations. Eur J Pharm Biopharm 55:191-198.
15. Srichana T, Suedee R, Reanmongkol W. 2001. Cyclodextrin as a potential drug carrier in salbutamol dry powder aerosols: The in vitro deposition and toxicity studies of the complexes. Respir Med 95:513-519.
16. Celebi N, Shirakura O, Machida Y, Nagai T. 1987. The inclusion complex of piromidic acid with dimethyl-beta-cyclodextrin in aqueous solution and in the solid state. J Inclusion Phenom 5:407.
17. Moyano JR, Arias-Blanco MJ, Gines JM, Perez-Martinez JI, Mor M, Giordano F. 1997. Nuclear magnetic resonance investigation of the inclusion complexation of gliclazide with beta-cyclodextrin. J Pharm Sci 86:72-75.
18. Loukas YL, Vraka V, Gregoriadis G. 1997. Novel non-acidic formulations of haloperidol complexed with beta-cyclodextrin derivatives. J Pharm Biomed Anal 16:263-268.
19. Lai S, Locci E, Piras A, Porcedda S, Lai A, Marongiu B. 2003. Imazalil-cyclomaltoheptaose (beta cyclodextrin) inclusion complex: Preparation by supercritical carbon dioxide and 13CPMAS and 1H NMR characterization. Carbohydr Res 338: 2227-2232.
20. Ikeda Y, Motoune S, Matsuoka T, Arima H, Hirayama F, Uekama K. 2002. Inclusion complex formation of captopril with alpha- and beta-cyclodextrins in aqueous solution: NMR spectroscopic and molecular dynamics studies. J Pharm Sci 91: 2390-2398.
21. Bekiroglu S, Kenne L, Sandstrom C. 2003. 1H NMR studies of maltose, maltoheptaose, alpha-, beta, and gamma- cyclodextrins, and complexes in aqueous solutions with hydroxyl protons as structural probes. J Org Chem 68:1671-1678.
22. 15N HSQS experiments optimized to retain full sensitivity. J Magn Res Ser A 102:241.
23. Eich G, Bodenhausen G, Ernst RR. 1982. Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy. J Am Chem Soc 104:3731.
24. Bax A, Davis DG. 1985. MELV-17 based two-dimensional homonuclear magnetization transfer spectroscopy. J Magn Res 65:355.
25. States DJ, Haberkon RA, Rubin DJ. 1982. A two-dimensional nuclear Overhauser experiment with pure absorption phase in four quadrants. J Magn Res 48:286.
26. Bax A, Davis DG. 1985. Practical aspects of two-dimensional transverse NOE spectroscopy. J Magn Res 63:207.
27. Stewart JJP. 1989. Optimization of parameters for semi-empirical methods. I. Method. J Comput Chem 10:209.
28. Stewart JJP. 1989. Optimization of parameters for semi-empirical methods. II. Applications. J Comput Chem 10:221.
29. Li X-S, Liu L, Mu T-W, Guo Q-X. 2000. A systematic quantum chemistry study on cyclodextrins. Monatshefte fur Chemie 131:849-855.
30. Thiel W, Voityuk AA. 1992. Extension of the MNDO formalism to d orbitale: Integral approximations and preliminary numerical results. Theoret Chem Acta 81:391-404.
31. Thiel W, Voityuk AA. 1992. Extension of MNDO to d orbitale: Parameters and results for the halogens. Intern J Quant Chem 44:807-829.
32. Desjardins RE, Canfield CJ, Chulay JD. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 16:710-718.
33. Chulay JD, Haynes JD, Diggs CL. 1983. Plasmodium falciparum: Assessment of in vitro growth by [3H]hypoxanthine incorporation. Exp Parasitol 55: 138-146.
34. Zuo Z, Kwon G, Stevenson B, Diakur J, Wiebe LI. 2000. Flutamide-hydroxypropyl-β-cyclodextrin complex: Formulation, physical characterization, and absorption studies using the caco-2 in vitro model. J Pharm Pharm Sci 3:220-227.
35. Benesi HA, Hilderbrand JHA. 1949. Spectrophotometric investigation of the interaction of iodine with aromatic hydrocarbons. J Am Chem Soc 71: 2703-2707.
36. Szejtli J. 1998. Introduction and general overview of cyclodextrin chemistry. Chem Rev 98:1743-1753.
37. Nishijo J, Nagai M, Yasuda M, Ohno E, Ushiroda Y. 1995. Interaction of 6-p-toluidinylnaphthalene-2-sulfonate with beta-cyclodextrin. J Pharm Sci 84: 1420-1426.
38. Redenti E, Ventura P, Fronza G, Selva A, Rivara S, Plazzi PV, Mor M. 1999. Experimental and theoretical analysis of the interaction of (+/-)-cis-ketoconazole with beta-cyclodextrin in the presence of (+)-L-tartaric acid. J Pharm Sci 88:599-607.
39. Redenti E, Szente L, Szejtli J. 2001. Cyclodextrin complexes of salts of acidic drugs. Thermodynamic properties, structural features, and pharmaceutical applications. J Pharm Sci 90:979-986.
40. Redenti E, Szente L, Szejtli J. 2000. Drug/cyclodextrin/hydroxy acid multicomponent systems. Properties and pharmaceutical applications. J Pharm Sci 89:1-8.
41. Illapakurthy AC, Sabnis YA, Avery BA, Avery MA, Wyandt CM. 2003. Interaction of artemisinin and its related compounds with hydroxypropyl-β- cyclodextrin in solution sate: Experimental and Molecular-modeling studies. J Pharm Sci 92:649-655.